The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment
Journal of Health Services Research & PolicyPublished 1 January 1997
Mark Sculpher, Michael Drummond, Martin Buxton
Citations211
SJR quartileQ1
SJR score1.05
SNIP1.06
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Four stages of economic analysis are suggested, starting with stage I when the basic clinical science is complete, and finishing with stage IV analysis to generalise the results of earlier studies to routine clinical practice.
Abstract
The economic evaluation of health care technologies has a key role within the new National Health Service health technology assessment process. There has, however, been little discussion of the best way of combining economic and clinical research. Economic evaluation should be iterative, generating progressively firmer estimates of cost-effectiveness and helping to maximise the efficiency of health care R&D. Here, four stages of economic analysis are suggested, starting with stage I when the basic clinical science is complete, and finishing with stage IV analysis to generalise the results of earlier studies to routine clinical practice.
Keywords
MedicineEconomics, Econometrics and FinanceHealth Professions
Operations ResearchClinical Decision Analysis
1,422 Citations1980Baruch Fischhoff
It is hoped that by considering the issues that a related profession has identified, the approaches it has developed to study those issues, and the (partial) conclusions it has reached, this work can facilitate the development of decision analysis.
Health EconomicsUncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis
526 Citations1994Andrew Briggs, Mark Sculpher +1 more
The types of uncertainty that exist in economic evaluation are reviewed and it is argued that some forms of uncertainty are not amenable to statistical methods.
Journal of Clinical EpidemiologyLarge-scale randomized evidence: Large, simple trials and overviews of trials
362 Citations1995Richard Peto, Rory Collins +1 more
Worldwide, hundreds of thousands of premature deaths a year could be avoided by seeking large-scale randomized evidence about various widely practicable treatments for the common causes of death, and by disseminating such evidence appropriately.
International Journal of Technology Assessment in Health CareEconomic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
341 Citations1991Michael Drummond, Linda Davies
Questions are discussed in trial design, collection of resource use data,Collection of outcome data, and interpretation and extrapolation of results about the closer integration of economic and clinical research.
Medical CareCost-Effectiveness of Strategies for Detecting Diabetic Retinopathy
188 Citations1991Erik J. Dasbach, Dennis G. Fryback +3 more
It was estimated that supplying annual examination with mydriatic fundus photography as a screening program to a cohort of 1,000 diabetics from the younger onset population who have been diagnosed at least 5 years and who are currently not receiving care might save 319 sight years over the lifetime of the cohort.
BJOG An International Journal of Obstetrics & GynaecologyAn economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia
147 Citations1993Mark Sculpher, Stirling Bryan +3 more
The relative health service cost of endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia and the value women attach to their health state before and after surgery are evaluated.
BMJCost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.
130 Citations1992Claes M. Gustafsson, Kjell Asplund +4 more
Treatment with anticoagulants and, if contraindications exist, with aspirin is cost effective provided that the risk of serious haemorrhage complications due to anticoaggulants is kept low.
JAMAReducing High Blood Cholesterol Level With Drugs
121 Citations1990Kevin A. Schulman
A cost-effectiveness analysis of pharmacologic treatment of high blood cholesterol levels suggest that niacin and lovastatin (20 mg/d) were most efficient for reducing cardiovascular risk.
PubMedCost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
106 Citations1994B O’Brien, David R. Anderson +1 more
The results of this study would be considered moderate to strong evidence to adopt enoxaparin prophylaxis against DVT after total hip replacement and the estimated incremental cost-effectiveness is $29 120 per life-year gained.
New England Journal of MedicineThe Swine-Influenza Decision
98 Citations1976Stephen C. Schoenbaum, Barbara J. McNeil +1 more
The economic aspects of mass immunization against swine-like influenza in 1976-1977 are analyzed, and the Delphi technic is used for estimating the likelihood and characteristics of an epidemic.
JAMAThe Case for Reassessment of Health Care Technology
93 Citations1990H. David Banta
This work examines four clinical practices--electronic fetal monitoring, episiotomy, electroencephalography, and hysterectomy--to illustrate the need to continuously reassess existing technologies and to challenge the current inertia in this critical arena of health practice.
PharmacoEconomicsStatistical Versus Quantitative Significance in the Socioeconomic Evaluation of Medicines
73 Citations1994Bernie J. OʼBrien, Michael Drummond
This article argues by analogy that the importance of differences in HRQOL require a shift of focus from the physician to the patient for preferences and judgements concerning what is important to them.
The LancetRandomised controlled trial of cost-effectiveness of lithotripsy and open cholecystectomy as treatments for gallbladder stones
57 Citations1992James Nicholl
Both lithotripsy and cholecystectomy gave significant health gains in terms of a reduction in episodes of biliary pain, improved perceived health status, and symptom relief, but few differences between treatments were found.
International Journal of Technology Assessment in Health CareA Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering Treatment
53 Citations1992Henry A. Glick, Joseph F. Heyse +4 more
Standard incidence-based techniques for measuring the cost of illness with logistic risk functions from the Framingham Heart Study are combined to project the likelihood of developing coronary heart disease over a lifetime as well as a number of related outcomes, including the expected loss of years of life due to CHD.
The American Journal of CardiologyClinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The Netherlands
52 Citations1990Léon L. Martens, Frans Rutten +2 more
Simvastatin therapy compares favorably with other generally accepted medical practices, especially if treatment is initiated at an early age, and may become accepted as a drug of first choice in the treatment of persons with elevated serum cholesterol levels.
International Journal of Technology Assessment in Health CareAnalysis of The National Institutes of Health Medicare Coverage Assessment
52 Citations1990Michael Dubinsky, John H. Ferguson
Analysis of NIH assessments indicates that even though most NIH assessments rely only on expert opinion, OHTA agreed with NIH recommendaations in over 90%.